Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-03-04

Clinical Trial Update: Treatment of Dry Eye Syndrome With Cyclosporin A Eye Drops [Phase 2]

View source ↗

Summary

A Phase 2 trial sponsored by the National Eye Institute evaluated cyclosporin A eye drops for dry eye syndrome in patients with Keratoconjunctivitis sicca and S…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cyclosporin A eye drops (cyclosporine A)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Keratoconjunctivitis Sicca, Sjogren's Syndrome | Phase 2 | Status: COMPLETED